1. Home
  2. VNDA vs PCB Comparison

VNDA vs PCB Comparison

Compare VNDA & PCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • PCB
  • Stock Information
  • Founded
  • VNDA 2002
  • PCB 2003
  • Country
  • VNDA United States
  • PCB United States
  • Employees
  • VNDA N/A
  • PCB N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • PCB Major Banks
  • Sector
  • VNDA Health Care
  • PCB Finance
  • Exchange
  • VNDA Nasdaq
  • PCB Nasdaq
  • Market Cap
  • VNDA 282.8M
  • PCB 265.5M
  • IPO Year
  • VNDA 2006
  • PCB N/A
  • Fundamental
  • Price
  • VNDA $4.77
  • PCB $18.70
  • Analyst Decision
  • VNDA Strong Buy
  • PCB Hold
  • Analyst Count
  • VNDA 2
  • PCB 2
  • Target Price
  • VNDA $16.50
  • PCB $22.00
  • AVG Volume (30 Days)
  • VNDA 652.5K
  • PCB 20.4K
  • Earning Date
  • VNDA 05-07-2025
  • PCB 04-24-2025
  • Dividend Yield
  • VNDA N/A
  • PCB 4.19%
  • EPS Growth
  • VNDA N/A
  • PCB N/A
  • EPS
  • VNDA N/A
  • PCB 1.74
  • Revenue
  • VNDA $198,772,000.00
  • PCB $96,309,000.00
  • Revenue This Year
  • VNDA $14.36
  • PCB $16.13
  • Revenue Next Year
  • VNDA $44.53
  • PCB $10.77
  • P/E Ratio
  • VNDA N/A
  • PCB $10.98
  • Revenue Growth
  • VNDA 3.18
  • PCB N/A
  • 52 Week Low
  • VNDA $3.71
  • PCB $14.50
  • 52 Week High
  • VNDA $6.75
  • PCB $22.20
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 48.67
  • PCB 43.15
  • Support Level
  • VNDA $4.84
  • PCB $18.34
  • Resistance Level
  • VNDA $5.04
  • PCB $19.31
  • Average True Range (ATR)
  • VNDA 0.22
  • PCB 0.40
  • MACD
  • VNDA -0.01
  • PCB 0.02
  • Stochastic Oscillator
  • VNDA 26.32
  • PCB 43.55

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals.

Share on Social Networks: